Clinical trial
Golimumab Effect in the Modulation of Gut Microbiota in Ulcerative Colitis: Pilot Study
NCT03018925 is registered in ClinicalTrials.gov with Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Golimumab Effect in the Modulation of Gut Microbiota in Ulcerative Colitis: Pilot Study
- Lead sponsor
- Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2016
- Completion date
- October 31, 2020
- Enrollment
- 15 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ulcerative colitis